The DOI matches its Crossref record.
Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin
Open accessAbstract
Genetically modified derivatives of cholera toxin (CT), harboring a single amino acid substitution in and around the NAD binding cleft of the A subunit, were isolated following site-directed mutagenesis of the ctxA gene. Two mutants of CT, designated CTS106 (with a proline-to-serine change at position 106) and CTK63 (with a serine-to-lysine change at position 63), were found to have substantially reduced ADP-ribosyltransferase activity and toxicity; CTK63 was completely nontoxic in all assays, whereas CTS106 was 10(4) times less toxic than wild-type CT. The mucosal adjuvanticity and immunogenicity of derivatives of CT were assessed by intranasal immunization of mice, with either ovalbumin or fragment C of tetanus toxin as a bystander antigen. Mice immunized with wild-type CT produced both local (immunoglobulin A in mucosal washes) and systemic immune responses to both CT and bystander antigens. CTS106 showed good local and systemic responses to bystander proteins and to itself. Interestingly, mice immunized with the nontoxic derivative of CT, CTK63, generated weak immune responses to the bystander antigens which were similar to those achieved when CT B subunit was used as an adjuvant. In parallel experiments, an equivalent nontoxic mutant of the Escherichia coli heat-labile enterotoxin, LTK63 (with a serine-to-lysine change at position 63), was tested (9). In contrast to CTK63, LTK63 was found to be more immunogenic and a better intranasal adjuvant than recombinant heat-labile enterotoxin B subunit or CTK63. This information, together with data on immunoglobulin subclass responses, suggests that although highly homologous, CT and heat-labile enterotoxin should not be considered biologically identical in terms of their ability to act as intranasal adjuvants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Singh, M., & O'Hagan, D. (1999) · Nature Biotechnology · doi:10.1038/15058 · Cited by 506
Recent developments in adjuvants for vaccines against infectious diseases
O'Hagan, D. T., MacKichan, M. L., & Singh, M. (2001) · Biomolecular Engineering · doi:10.1016/s1389-0344(01)00101-0 · Cited by 332
Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants
Pizza, M., Giuliani, M. M., Fontana, M. R., Monaci, E., Douce, G., Dougan, G., Mills, K. H. G., Rappuoli, R., & Del Giudice, G. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00553-3 · Cited by 304
Self-citationStructure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins
Rappuoli, R., Pizza, M., Douce, G., & Dougan, G. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01523-6 · Cited by 284
Self-citationCholera toxin induces maturation of human dendritic cells and licences them for Th2 priming
Gagliardi, M. C., Sallusto, F., Marinaro, M., Langenkamp, A., Lanzavecchia, A., & De Magistris, M. T. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(2000)30:8<2394::aid-immu2394>3.0.co;2-y · Cited by 278
Metadata
- Authors
- Douce, G., Fontana, M., Pizza, M., Rappuoli, R., & Dougan, G.
- Venue
- Infection and Immunity
- Publisher
- American Society for Microbiology
- Published
- 1997-07
- Volume
- 65
- Issue
- 7
- Pages
- 2821-2828
- ISSN
- 0019-9567 (ISSN-L)
- 1098-5522
- OpenAlex
- W2171387123
- Cited by
- 167
- References
- 0
- FWCI
- 8.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin. https://app.cochat.ai/papers/10.1128/iai.65.7.2821-2828.1997
- The paper
- Douce, G., Fontana, M., Pizza, M., Rappuoli, R., & Dougan, G. (1997). Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin. Infection and Immunity. https://doi.org/10.1128/iai.65.7.2821-2828.1997
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.